Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies

References

• Azmin MN, Florence AT, Handjani-Vila RM, et al. (1985). The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm Pharmacol 37:237–42
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. (2004). Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649–59
   PubMed Web of Science ®Google Scholar
• Brigger I, Dubernet C, Couvreur P. (2002). Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631–51
   PubMed Web of Science ®Google Scholar
• Chen M, Rose AE, Doudican N, et al. (2009). Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells. Mol Cancer Res 7:1946–53
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng S-S. (2007). PLGA nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. Int J Pharm 342:208–14
   PubMed Web of Science ®Google Scholar
• Feng SS. (2004). Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices 1:115–25
   PubMed Web of Science ®Google Scholar
• Gabathuler R. (2010). Approaches to transport therapeutic drugs across the blood brain barrier to treat brain diseases. Neurobiol Dis 37:48–57
   PubMed Web of Science ®Google Scholar
• Goel PN, Gude RP. (2011). Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells. Mol Cell Biochem 358:141–51
   PubMed Web of Science ®Google Scholar
• Goel PN, Gude RP. (2014). Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells. Biomed Pharmacother 68:191–200
   PubMed Web of Science ®Google Scholar
• Groothuis DR. (2000). The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro-Oncology 2:45–59
   PubMed Web of Science ®Google Scholar
• Huang RQ, Qu YH, Ke WL, et al. (2007). Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J 21:1117–25
   PubMed Web of Science ®Google Scholar
• Jain D, Athawale R, Bajaj A, et al. (2013a). Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles. Colloids Surf B Biointerfaces 109:59–67
   PubMed Web of Science ®Google Scholar
• Jain D, Athawale R, Bajaj A, et al. (2013b). Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 glioma cells. Biomed Aging path 3:201–8
   Google Scholar
• Jain D, Athawale R, Bajaj A, et al. (2014). Unraveling the cytotoxic potential of temozolomide loaded into PLGA nanoparticles. DARU J Pharm Sci 22:1–9
   Web of Science ®Google Scholar
• Kreuter J, Ramge P, Petrov V, et al. (2003). Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res 20:409–16
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75:1–18
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Yamamoto H, et al. (2001). Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther 299:775–81
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. (2005). Praziquantel-loaded PLGA nanoparticles: preparation and characterization. J Microencapsul 22:13–24
   PubMed Web of Science ®Google Scholar
• Miura H, Onishi H, Sasatsu M, Machida Y. (2004). Antitumor characteristics of methoxypolyethylene glycol-poly(DL-lactic acid) nanoparticles containing camptothecin. J Control Release 97:101–13
   PubMed Web of Science ®Google Scholar
• Mo Y, Lim LY. (2005). Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate. J Control Release 107:30–42
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. (2005). Nanomedicine: current status and future prospects. FASEB J 19:311–30
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86:33–48
   PubMed Web of Science ®Google Scholar
• Nerkar N, Bajaj A, Shrikhande S, Jain D. (2012). Fabrication of lipospheres for paclitaxel and assessment of in vitro cytotoxicity against U373 cancer cell lines. Thai J Pharm Sci 36:117–30
   Google Scholar
• Pardridge WM. (2005). The blood-brain barrier: bottleneck in brain drug development. NeuroRX 2:3–14
   PubMedGoogle Scholar
• Potineni A, Lynn DM, Langer R, Amiji MM. (2003). Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. J Control Release 86:223–34
   PubMed Web of Science ®Google Scholar
• Shegokar R, Jansch M, Singh KK, Muller RH. (2011). In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy. Nanomedicine 7:333–40
   PubMed Web of Science ®Google Scholar
• Straub JA, Chickering DE, Lovely JC, et al. (2005). Intravenous hydrophobic drug delivery: a porous particle formulation of paclitaxel (AI-850). Pharm Res 22:347–55
   PubMed Web of Science ®Google Scholar
• Tian XH, Lin XN, Wei F, et al. (2011). Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomedicine 6:445–52
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu W, Xu H, Yang X. (2007). Preparation and in vitro studies of stealth PEGylated PLGA nanoparticles as carriers for arsenic trioxide. Chinese J Chem Eng 15:795–801
   Web of Science ®Google Scholar
• Xu Z, Gu W, Huang J, et al. (2005). In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm 288:361–8
   PubMed Web of Science ®Google Scholar